Argus raises Jabil stock price target on AI growth outlook By Investing.com

Jabil reported Q2 FY2026 EPS $2.69 vs $2.49 consensus (beat $0.20) and revenue $8.3B, $550M ahead of forecasts; management raised FY revenue guidance to $34.0B (from $32.4B, +$1.6B, ~4.9%) and non-GAAP EPS to $12.25 (from $11.55, +$0.70, ~6.1%). Multiple brokers lifted price targets (Argus to $300 from $250; BofA $295; Raymond James $300; Barclays $304) and the stock has returned ~86% over the past year, trading at $259 (market cap $27.3B). Management cited a multi‑billion AI revenue opportunity and aggressive US facility investment, but risks include supply‑chain constraints, geopolitical exposure and a valuation flagged as above fair value by InvestingPro.

Analysis

Jabil’s strategic pivot — aggressive U.S. capacity adds aimed at AI infrastructure — creates a clear winners list beyond the company itself: hyperscalers and large component suppliers that can scale with multi‑site EMS partners will see shorter lead times and firmer pricing power, while smaller regional EMS providers are exposed to margin pressure and potential customer defection. The U.S. facility build is a double‑edged sword: it accelerates contract wins but also frontloads fixed costs and local wage inflation, so near‑term margin volatility is likely even as structural revenue runway lengthens.

Key risks cluster around order phasing and supply constraints. In days-weeks, sentiment and positioning can swing on booking disclosures or trade‑policy headlines; over 3–12 months the picture will be decided by utilization rates at new plants and inventory turns at major customers; over 2–5 years the story depends on whether AI capex remains a durable, repeatable cycle rather than a multi‑year lumpy upgrade wave. Watch cadence indicators — disclosed AI customer wallet share, backlog conversion, and days‑sales‑outstanding — as real catalysts that will re‑rate peers and suppliers.

The consensus appears to price near‑perfect execution; that’s a vulnerable stance. If execution slips or if customers elect to internalize specialized modules, multiple compression could be swift given the recent run. For active portfolios, the question isn’t whether Jabil benefits from AI, but whether that benefit is sufficiently de‑risked versus capex, supply‑chain and geopolitical tail risks to justify the prevailing valuation premium.

Key Decisions for Investors

• Directional, capped upside: Buy JBL via a 9‑12 month 20–30% OTM call spread (long the lower call, sell the higher) to capture continued AI order flow while capping premium spend. R/R: target 35–60% return on premium if execution evidence solidifies; max loss = premium. Exit on miss of two consecutive quarter‑over‑quarter AI revenue updates or utilization below 70%.
• Relative play: Pair trade long JBL / short FLEX (equal notional) for 6–12 months to express share shift toward scale‑biased EMS contractors. R/R: expect 10–25% pair outperformance if Jabil’s U.S. capacity wins incremental hyperscaler business; risk is sectorwide re‑rating lifting both names — cut at pair breakeven if overall EMS index rallies >15% in 60 days.
• Protective hedge for existing longs: Buy 3–6 month puts ~12–18% OTM or implement collars to limit downside from inventory correction or geopolitical shock. Cost: expect ~2–6% of position value; benefit: caps single‑event drawdowns while retaining multi‑quarter upside.
• Event/volatility trade (short term): If you believe current optimism is fully baked, sell 30–45 day covered calls against a reduced JBL position to harvest IV into potential disappointment after upcoming earnings/capex updates. R/R: generates 1–3% income per month; risk = forfeiting upside beyond strike and limited downside cushion from premium.